Annals of Hepatology (May 2022)

Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study

  • Stefano Gitto,
  • Paolo Magistri,
  • Luca Marzi,
  • Nicolò Mannelli,
  • Nicola De Maria,
  • Andrea Mega,
  • Giovanni Vitale,
  • Giovanna Valente,
  • Francesco Vizzutti,
  • Erica Villa,
  • Fabio Marra,
  • Pietro Andreone,
  • Margherita Falcini,
  • Barbara Catellani,
  • Gian Piero Guerrini,
  • Valentina Serra,
  • Stefano Di Sandro,
  • Roberto Ballarin,
  • Guido Piai,
  • Filippo Schepis,
  • Marzia Margotti,
  • Carmela Cursaro,
  • Paolo De Simone,
  • Stefania Petruccelli,
  • Paola Carrai,
  • Paolo Forte,
  • Claudia Campani,
  • Heinz Zoller,
  • Fabrizio Di Benedetto

Journal volume & issue
Vol. 27, no. 3
p. 100683

Abstract

Read online

Introduction and objectives: De novo malignancies represent an important cause of death for liver transplant recipients. Our aim was to analyze predictors of extra-hepatic non-skin cancer (ESNSC) and the impact of ESNSC on the long-term outcome. Patients: We examined data from patients transplanted between 2000 and 2005 and followed-up in five Italian transplant clinics with a retrospective observational cohort study. Cox Regression was performed to identify predictors of ESNSC. A 1:2 cohort sub-study was developed to analyze the impact of ESNSC on 10-year survival. Results: We analyzed data from 367 subjects (median follow-up: 15 years). Patients with ESNSC (n = 47) more often developed post-LT diabetes mellitus (DM) (57.4% versus 35,9%, p = 0.004). At multivariate analysis, post-LT DM independently predicted ESNSC (HR 1.929, CI 1.029-3.616, p = 0.040). Recipients with ESNSC showed a lower 10-year survival than matched controls (46,8% versus 68,1%, p = 0.023). Conclusions: Post-LT DM seems to be a relevant risk factor for post-LT ESNSC. ESNSC could have a noteworthy impact on the long-term survival of LT recipients.

Keywords